🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Immediate-Release Aspirin Tablets

Found 10 matching trials

Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers

PHASE3

This study uses an open-label design and will be conducted in approximately...

Status

Completed

Location

Pozen

Start Date

2009-10

Trial ID

NCT00995410

Treatments Being Tested

PA32540

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

PHASE3

Primary: To demonstrate that PA32540 causes fewer gastric ulcers in subject...

Status

Completed

Location

Pozen

Start Date

2009-10

Trial ID

NCT00960869

Treatments Being Tested

PA32540 EC-Aspirin 325 mg

Pathways of Eicosanoid Metabolism

EARLY_PHASE1

Prostaglandins are important signaling compounds formed from arachidonic ac...

Status

Enrolling By Invitation

Location

Vanderbilt University

Start Date

2020-08-15

Trial ID

NCT04464070

Treatments Being Tested

niacin aspirin PGD2

Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately

PHASE1

The purpose of this study is to investigate whether a fixed dose combinatio...

Status

Terminated

Location

Research Site

Start Date

2009-11

Trial ID

NCT01015729

Treatments Being Tested

Esomeprazole/ASA Fixed Combination Esomeprazole ASA

A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

PHASE3

Primary: To demonstrate that PA32540 causes fewer gastric ulcers in subject...

Status

Completed

Location

Pozen

Start Date

2009-10

Trial ID

NCT00961350

Treatments Being Tested

PA32540 EC Aspirin 325

Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately

PHASE1

The purpose of this study is to investigate whether treatment with a combin...

Status

Completed

Location

Research Site

Start Date

2009-09

Trial ID

NCT00998075

Treatments Being Tested

Esomeprazole/ASA Fixed Combination Esomeprazole - Nexium ASA

Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients

PHASE3

This study will determine if aspirin from PL2200, an investigational produc...

Status

Completed

Location

MedPace Clinical Pharmacology

Start Date

2012-01

Trial ID

NCT01515657

Treatments Being Tested

PL2200 Aspirin Capsules Immediate-Release Aspirin Tablets Enteric-coated aspirin caplets

Randomized, Crossover Bioequivalence Study of PL-ASA Versus Immediate Release Aspirin in Healthy Volunteers.

PHASE1

This trial is a randomized, actively-controlled, open-label, 2-way crossove...

Status

Completed

Location

PRA-EDS

Start Date

2020-05-07

Trial ID

NCT05055752

Treatments Being Tested

Pharmaceutical-lipid aspirin (PL-ASA)

A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540

PHASE1

This study is designed to provide data on platelet aggregation of PA32540 p...

Status

Completed

Location

Sinai Center for Thrombosis Research

Start Date

2010-11

Trial ID

NCT01557335

Treatments Being Tested

Plavix® and PA32540 EC aspirin (Bayer®) ,EC omeprazole (Prilosec®) , Clopidogrel (Plavix®)

Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects

PHASE1

Comparative Pharmacokinetics of Asasantin Extended Release (ER) and of imme...

Status

Completed

Location

Multiple Locations

Start Date

2000-04

Trial ID

NCT02273505

Treatments Being Tested

Asasantin (ER)Persantin Acetyl salicylic acid (ASA)

Previous Next